5 recruiting. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Recruiting 5 |
| Phase 1 | 1 | Recruiting 1 |
Follow Lymphopenia: new trials by email Literature Review of Lymphopenia trials Research Report on Lymphopenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors PRaG-1, Placebo - Solid Cancer, Lymphopenia | Phase 2 | Recruiting | Second Affiliated Hospital of Soochow University | 127 | 2025-12-01 | 2026-01-09 |
| PRaG-1 Plus PRaG Therapy in in Elderly Patients With Advanced Solid Tumors: A Prospective Clinical Trial (PRaG 10.0) PD -1/PD-L1 monoclonal antibody - Solid Cancer, Lymphopenia | Phase 2 | Recruiting | Second Affiliated Hospital of Soochow University | 65 | 2025-12-01 | 2026-10-27 |
| A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia Recombinant human interleukin (IL) 7-hyFc - Idiopathic CD4 Lymphopenia | Phase 1 / Phase 2 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 60 | 2024-11-06 | 2026-10-19 |
| Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors Thymalfasin for injection in combination with Recombinant Human Interleukin-2 Injections, Recombinant Human Interleukin-2 Injections - Hematological Malignancy, Lymphocytopenia | Phase 2 | Recruiting | The First Affiliated Hospital of Xiamen University | 50 | 2024-09-01 | 2024-09-19 |
| Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT Hydroxyurea, Alemtuzumab, Fludarabine - Primary Immunodeficiency (PID), Congenital Bone Marrow Failure Syndromes | Phase 2 | Recruiting | Paul Szabolcs | 100 | 2014-02-04 | 2025-12-15 |
Adrenoleukodystrophy (1) · Anemia, Diamond-Blackfan (1) · Anemia, Sickle Cell (1) · Arthritis, Juvenile (1) · Autoimmune Lymphoproliferative Syndrome (1) · Chediak-Higashi Syndrome (1) · Congenital Bone Marrow Failure Syndromes (1) · Congenital amegakaryocytic thrombocytopenia (1) · Crohn Disease (1) · Dyskeratosis Congenita (1) · Gaucher Disease (1) · Granulomatous Disease, Chronic (1) · Hematologic Neoplasms (1) · Hereditary Diffuse Leukoencephalopathy with Spheroids (1)
Cytopenia (5) · Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Immune System Diseases (5) · Immunologic Deficiency Syndromes (5) · Leukocyte Disorders (5) · Leukopenia (5) · Adrenal Gland Diseases (1) · Adrenal Insufficiency (1) · Albinism (1) · Anemia (1) · Anemia, Aplastic (1) · Anemia, Hemolytic (1) · Anemia, Hemolytic, Congenital (1)
Alemtuzumab (1) · Hydroxyurea (1) · Injections (1) · Melphalan (1) · Thiotepa (1) · Thymalfasin (1) · fludarabine (1) · fludarabine phosphate (1)
Second Affiliated Hospital of Soochow University (2) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Paul Szabolcs (1) · The First Affiliated Hospital of Xiamen University (1)
China (3) · United States (2)
Andrea Lisco, M.D. (1) · Paul Szabolcs, MD (1) · Zhijuan Lin (1)